U.S. Radiation Oncology Market Size, Share & Trends Analysis Report By Type (External Beam Radiation Therapy, Internal Beam Radiation Therapy), By Technology, By Application, And Segment Forecasts, 2020 - 2027
This report can be delivered to the clients within 24 Business Hours
The U.S. Radiation Oncology Market Growth & Trends
The U.S. radiation oncology market size is expected to reach USD 3.9 billion by 2027, expanding at a CAGR of 5.0%, according to a new report by Grand View Research, Inc. Increasing the prevalence of cancer and technological advancements in radiation oncology are some of the key factors responsible for market growth.
Advancements in technologies are anticipated to reduce the adverse effects of radiotherapy and improve its overall quality. In addition, newer therapies tend to be more efficient than their traditional counterparts. For instance, SBRT was found to be efficient in treating laryngeal cancer with only five treatment fractions, as per a clinical trial that is expected to be completed by 2021.
Advancements in radiation oncology can enable the delivery of a high dose to a target area without any damage to adjacent healthy tissues. This has increased the chances of localized tumor control and improved cure rates, leading to an increase in demand for the therapy. Therefore, hospitals and ambulatory healthcare providers are installing more equipment, which, in turn, is boosting the market growth.
For instance, according to OECD, in the U.S., the number of radiotherapy equipment, which included linear accelerators, Caesium-137 therapy units, Cobalt-60 units, HDR and LDR brachytherapy units, and conventional brachytherapy units, was 11.7 per 1000,000 inhabitants in 2019.
In addition, increasing radiotherapy centers in the U.S. is anticipated to boost the market growth. In January 2020, the University of Alabama at Birmingham inaugurated its proton therapy center of Proton International. The center was formed through a partnership between Proton International and the UAB. Out of 36 proton cancer centers in the U.S., Proton International at UAB was the first facility opened in Alabama.
The high adoption of cyclotrons is anticipated to drive the market. For instance, in March 2019, the University of Alabama at Birmingham installed a 90-ton cyclotron in its proton therapy center. Installation of a cyclotron will drive R&D activities in the country and help meet the demand for isotopes.
Key players tend to undertake strategic initiatives such as collaborations, licensing, and partnerships to adopt new systems that can reduce cost and space; such initiatives are expected to drive the market. For instance, in June 2020, Accuray Incorporated launched the CyberKnife S7 System, which offers advanced technologies including real-time AI-driven motion tracking and synchronized treatment delivery. It can provide all SBRT treatments and Stereotactic Radio Surgeries (SRS) within 15 minutes.
The U.S. Radiation Oncology Market Report Highlights
The U.S. Radiation Oncology Market Growth & Trends
The U.S. radiation oncology market size is expected to reach USD 3.9 billion by 2027, expanding at a CAGR of 5.0%, according to a new report by Grand View Research, Inc. Increasing the prevalence of cancer and technological advancements in radiation oncology are some of the key factors responsible for market growth.
Advancements in technologies are anticipated to reduce the adverse effects of radiotherapy and improve its overall quality. In addition, newer therapies tend to be more efficient than their traditional counterparts. For instance, SBRT was found to be efficient in treating laryngeal cancer with only five treatment fractions, as per a clinical trial that is expected to be completed by 2021.
Advancements in radiation oncology can enable the delivery of a high dose to a target area without any damage to adjacent healthy tissues. This has increased the chances of localized tumor control and improved cure rates, leading to an increase in demand for the therapy. Therefore, hospitals and ambulatory healthcare providers are installing more equipment, which, in turn, is boosting the market growth.
For instance, according to OECD, in the U.S., the number of radiotherapy equipment, which included linear accelerators, Caesium-137 therapy units, Cobalt-60 units, HDR and LDR brachytherapy units, and conventional brachytherapy units, was 11.7 per 1000,000 inhabitants in 2019.
In addition, increasing radiotherapy centers in the U.S. is anticipated to boost the market growth. In January 2020, the University of Alabama at Birmingham inaugurated its proton therapy center of Proton International. The center was formed through a partnership between Proton International and the UAB. Out of 36 proton cancer centers in the U.S., Proton International at UAB was the first facility opened in Alabama.
The high adoption of cyclotrons is anticipated to drive the market. For instance, in March 2019, the University of Alabama at Birmingham installed a 90-ton cyclotron in its proton therapy center. Installation of a cyclotron will drive R&D activities in the country and help meet the demand for isotopes.
Key players tend to undertake strategic initiatives such as collaborations, licensing, and partnerships to adopt new systems that can reduce cost and space; such initiatives are expected to drive the market. For instance, in June 2020, Accuray Incorporated launched the CyberKnife S7 System, which offers advanced technologies including real-time AI-driven motion tracking and synchronized treatment delivery. It can provide all SBRT treatments and Stereotactic Radio Surgeries (SRS) within 15 minutes.
The U.S. Radiation Oncology Market Report Highlights
- External Beam Radiotherapy (EBRT) dominated the market in 2019 owing to innovation in technology used in cancer treatment and an increase in the prevalence of cancer
- In 2019, Electron-emitting high energy linear accelerators held the largest revenue share as a result of an increase in usage due to technological revolution, an increase in capability to provide precise treatment services, and favorable reimbursement policies
- On the basis of technology, Intensity Modulated Radiotherapy (IMRT) dominated the application segment in 2019 due to its ability to change radiation intensity during treatment so as to specifically target cancer cells and limit the damage to adjoining healthy tissues
- In application, internal beam radiation therapy is estimated to witness the fastest growth rate during the forecast period owing to the cost-effectiveness and accuracy of brachytherapy.
CHAPTER 1 METHODOLOGY AND SCOPE
1.1 Market Segmentation and Scope
1.1.1 Segment Scope
1.1.2 Country Scope
1.1.3 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database:
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach: Commodity Flow Approach
1.7 List Of Secondary Sources
1.8 List Of Abbreviations
1.9 Objectives
1.9.1 Objective
1.9.2 Objective
1.9.3 Objective
1.9.4 Objective
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Summary
CHAPTER 3 MARKET VARIABLES, TRENDS & SCOPE
3.1 Market Segmentation
CHAPTER 4 MARKET DEFINITIONS
CHAPTER 5 INDUSTRY OUTLOOK
5.1 Key Opportunities Prioritized
5.2 Market Dynamics
5.2.1 Rising Adoption Of Radiotherapy
5.2.2 Technological Advancements In Radiotherapy
5.2.3 Rising Prevalence Of Cancer
5.2.4 Increase In Healthcare Expenditure
5.2.5 Favorable Reimbursement Scenario
5.3 Market Restraint Analysis
5.3.1 Lack Of Skilled Radiotherapy Professionals
5.3.2 Adverse Effects Of Radiotherapy
5.4 Swot Analysis; By Factor (Political & Legal, Economic And Technological)
5.5 Porter’s Five Forces Analysis
5.6 Regulatory Framework
CHAPTER 6 THE U.S. RADIATION ONCOLOGY MARKET - SEGMENT ANALYSIS, BY TYPE, 2016 - 2027 (USD MILLION)(VOLUME, NUMBER OF UNITS)
6.1 The U.S. Radiation Oncology Market: Type Movement Analysis
6.2 External Beam Radiation Therapy
6.2.1 External Beam Radiation Therapy Market, 2016 - 2027 (USD Million)
6.2.2 external Beam Radiation Therapy Market, 2016 - 2027 (Volume, Number Of Units)
6.2.3 Electron-Emitting High Energy Linear Accelerators
6.2.3.1 Electron-Emitting High Energy Linear Accelerators Market, 2016 - 2027 (USD Million)
6.2.3.2 Electron-Emitting High Energy Linear Accelerators Market, 2016 - 2027 (Volume, Number Of Units)
6.2.4 Compact Advanced Radiotherapy Systems
6.2.4.1 Compact Advanced Radiotherapy Systems Market, 2016 - 2027 (USD Million)
6.2.4.2 compact Advanced Radiotherapy Systems Market, 2016 - 2027 (Volume, Number Of Units)
6.2.4.3 Cyberknife
6.2.4.3.1 Cyberknife Market, 2016 - 2027 (USD Million)
6.2.4.4 Gamma Knife
6.2.4.4.1 Gamma Knife Market, 2016 - 2027 (USD Million)
6.2.4.5 Tomotherapy
6.2.4.5.1 Tomotherapy Compact Market, 2016 - 2027 (USD Million)
6.2.5 Proton Therapy
6.2.5.1 Proton Therapy Market, 2016 - 2027 (USD Million)
6.2.5.2 Proton Therapy Market, 2016 - 2027 (Volume, Number Of Units)
6.2.5.3 Cyclotron
6.2.5.3.1 Cyclotron Market, 2016 - 2027 (USD Million)
6.2.5.4 Synchrotron
6.2.5.4.1 Synchrotron Market, 2016 - 2027 (USD Million)
6.3 Internal Beam Radiation Therapy
6.3.1 Internal Beam Radiation Therapy Market, 2016 - 2027 (USD Million)
6.3.2 Internal Beam Radiation Therapy Market, 2016 - 2027 (Volume, Number Of Units)
6.3.3 Brachytherapy
6.3.3.1 Brachytherapy Market, 2016 - 2027 (USD Million)
6.3.3.2 Brachytherapy Market, 2016 - 2027 (Volume, Number Of Units)
6.3.3.3 Seeds
6.3.3.3.1 Seeds Market, 2016 - 2027 (USD Million)
6.3.3.4 Applicators And After-Loaders
6.3.3.4.1 Applicators And After-Loaders Market, 2016 - 2027 (USD Million)
6.3.3.4 Electronic Brachytherapy
6.3.3.4.1 Electronic Brachytherapy Market, 2016 - 2027 (USD Million)
6.3.4 Systemic Beam Radiation Therapy
6.3.4.1 Systemic Beam Radiation Therapy Market, 2016 - 2027 (USD Million)
6.3.3.2 Brachytherapy Market, 2016 - 2027 (Volume, Number Of Units)
6.3.5 Others
6.3.5.1 Others Market, 2016 - 2027 (USD Million)
CHAPTER 7 THE U.S. RADIATION ONCOLOGY MARKET - SEGMENT ANALYSIS, BY TECHNOLOGY, 2016 - 2027 (USD MILLION)(VOLUME, NUMBER OF UNITS)
7.1 The U.S. Radiation Oncology Market: Technology Movement Analysis
7.2 External Beam Radiation Therapy (Ebrt)
7.2.1 Ebrt Market, 2016 - 2027 (USD Million)
7.2.2 Ebrt Market, 2016 - 2027 (Volume, Number Of Procedures)
7.2.3 Image-Guided Radiation Therapy (Igrt)
7.2.3.1 Igrt Market, 2016 - 2027 (USD Million)
7.2.3.2 Igrt Market, 2016 - 2027 (Volume, Number Of Procedures)
7.2.4 Intensity Modulated Radiotherapy (Imrt)
7.2.4.1 Imrt Market, 2016 - 2027 (USD Million)
7.2.4.2imrt Market, 2016 - 2027 (Volume, Number Of Procedures)
7.2.5 Stereotactic Radiotherapy
7.2.5.1 Stereotactic Radiotherapy Market, 2016 - 2027 (Volume, Number Of Procedures)
7.2.5.2stereotactic Radiotherapy Market, 2016 - 2027 (USD Million)
7.2.6 Proton Beam Therapy
7.2.6.1 Proton Beam Therapy Market, 2016 - 2027 (USD Million)
7.2.6.2proton Beam Therapy Market, 2016 - 2027 (Volume, Number Of Procedures)
7.2.7 3d Conformal Radiotherapy (3d-Crt)
7.2.7.1 3d-Crt Market, 2016 - 2027 (USD Million)
7.2.7.2 3d-Crt Market, 2016 - 2027 (Volume, Number Of Procedures)
7.2.8 Volumetric Modulated Arc Therapy (Vmat)
7.2.8.1 Vmat Market, 2016 - 2027 (USD Million)
7.2.8.2vmat Market, 2016 - 2027 (Volume, Number Of Procedures)
7.3 Brachytherapy
7.3.1 Brachytherapy Market, 2016 - 2027 (USD Million)
7.3.2 Brachytherapy Market, 2016 - 2027 (Volume, Number Of Units)
7.3.3 Low Dose Rate (Ldr) Brachytherapy
7.3.3.1 Ldr Brachytherapy Market, 2016 - 2027 (USD Million)
7.3.3.2ldr Brachytherapy Market, 2016 - 2027 (Volume, Number Of Units)
7.3.4 High Dose Rate (Hdr) Brachytherapy
7.3.4.1 Hdr Brachytherapy Market, 2016 - 2027 (USD Million)
7.3.4.2 hdr Brachytherapmarket, 2016 - 2027 (Volume, Number Of Units)
CHAPTER 8 THE U.S. RADIATION ONCOLOGY MARKET - SEGMENT ANALYSIS, BY APPLICATION, 2016 - 2027 (USD MILLION)(VOLUME, NUMBER OF PROCEDURES)
8.1 The U.S. Radiation Oncology Market: Application Movement Analysis
8.2 External Beam Radiation Therapy (Ebrt)
8.2.1 Prostate Cancer
8.2.1.1 Prostate Cancer Market, 2016 - 2027 (USD Million)
8.2.1.2 Prostate Cancer Market, 2016 - 2027 (Volume, Number Of Procedures)
8.2.2 Breast Cancer
8.2.2.1 Breast Cancer Market, 2016 - 2027 (USD Million)
8.2.2.2 Breast Cancer Market, 2016 - 2027 (Volume, Number Of Procedures)
8.2.3 Lung Cancer
8.2.3.1 Lung Cancer Market, 2016 - 2027 (USD Million)
8.2.3.2 Lung Cancer Market, 2016 - 2027 (Volume, Number Of Procedures)
8.2.4 Head And Neck Cancer
8.2.4.1 Head And Neck Cancer Market, 2016 - 2027 (USD Million)
8.2.4.2 Head And Neck Cancer Market, 2016 - 2027 (Volume, Number Of Procedures)
8.2.5 Colorectal cancer
8.2.5.1 Colorectal Cancer Market, 2016 - 2027 (USD Million)
8.2.5.2 Colorectal Cancer Market, 2016 - 2027 (Volume, Number Of Procedures)
8.2.6 Others
8.2.6.1 Others Market, 2016 - 2027 (USD Million)
8.3 Internal Beam Radiation Therapy
8.3.1 Prostate Cancer
8.3.1.1 Prostate Cancer Market, 2016 - 2027 (USD Million)
8.3.1.2 Prostate Cancer Market, 2016 - 2027 (Volume, Number Of Procedures)
8.3.2 Gynecologic Cancer
8.3.2.1 Gynecologic Cancer Market, 2016 - 2027 (USD Million)
8.3.2.2 Gynecologic Cancer Market, 2016 - 2027 (Volume, Number Of Procedures)
8.3.3 Breast Cancer
8.3.3.1 Breast Cancer Market, 2016 - 2027 (USD Million)
8.3.3.2 Breast Cancer Market, 2016 - 2027 (Volume, Number Of Procedures N)
8.3.4 Cervical Cancer
8.3.4.1 Cervical Cancer Market, 2016 - 2027 (USD Million)
8.3.4.2 Cervical Cancer Market, 2016 - 2027 (Volume, Number Of Procedures)
8.3.5 Penile Cancer
8.3.5.1 Penile Cancer Market, 2016 - 2027 (USD Million)
8.3.5.2 Penile Cancer Market, 2016 - 2027 (Volume, Number Of Procedures)
8.3.6 Others
8.3.6.1 Others Market, 2016 - 2027 (USD Million)
CHAPTER 9 COMPETITIVE LANDSCAPE
9.1 Strategic Framework
9.2 Company Profiles
9.2.1 Varian Medical Systems, Inc.
9.2.1.1 Company Overview
9.2.1.2 Financial Performance
9.2.1.3 Product Benchmarking
9.2.1.4 Strategic Initiatives
9.2.2 Elekta Ab
9.2.2.1 Company Overview
9.2.2.2 Financial Performance
9.2.2.3 Product Benchmarking
9.2.2.4 Strategic Initiatives
9.2.3 Accuray Inc.
9.2.3.1 Company Overview
9.2.3.2 Financial Performance
9.2.3.3 Product Benchmarking
9.2.3.4 Strategic Initiatives
9.2.4 C.R. Bard, Inc.
9.2.4.1 Company Overview
9.2.4.2 Financial Performance
9.2.4.3 Product Benchmarking
9.2.4.4 Strategic Initiatives
9.2.5 Mevion Medical Systems
9.2.5.1 Company Overview
9.2.5.2 Product Benchmarking
9.2.5.3 Strategic Initiatives
9.2.6 Ion Beam Applications (Iba).
9.2.6.1 Company Overview
9.2.6.2 Financial Performance
9.2.6.3 Product Benchmarking
9.2.6.4 Strategic Initiatives
9.2.7 Curium
9.2.7.1 Company Overview
9.2.7.2 Product Benchmarking
9.2.8 Nordion Inc.
9.2.8.1 Company Overview
9.2.8.2 Product Benchmarking
9.2.8.3 Strategic Initiatives
9.3 Vendor Landscape
9.3.1 List Of Key Distributors And Channel Partners
9.3.2 Key Company Market Share Analysis, 2019
9.4 Public Companies
9.4.1 Company Market Position Analysis
9.4.2 Competitive Dashboard Analysis
9.5 Private Companies
9.5.1 List Of Key Emerging Companies /Technology Disruptors/Innovators
9.5.2 Geographical Network Map
1.1 Market Segmentation and Scope
1.1.1 Segment Scope
1.1.2 Country Scope
1.1.3 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database:
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach: Commodity Flow Approach
1.7 List Of Secondary Sources
1.8 List Of Abbreviations
1.9 Objectives
1.9.1 Objective
1.9.2 Objective
1.9.3 Objective
1.9.4 Objective
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Summary
CHAPTER 3 MARKET VARIABLES, TRENDS & SCOPE
3.1 Market Segmentation
CHAPTER 4 MARKET DEFINITIONS
CHAPTER 5 INDUSTRY OUTLOOK
5.1 Key Opportunities Prioritized
5.2 Market Dynamics
5.2.1 Rising Adoption Of Radiotherapy
5.2.2 Technological Advancements In Radiotherapy
5.2.3 Rising Prevalence Of Cancer
5.2.4 Increase In Healthcare Expenditure
5.2.5 Favorable Reimbursement Scenario
5.3 Market Restraint Analysis
5.3.1 Lack Of Skilled Radiotherapy Professionals
5.3.2 Adverse Effects Of Radiotherapy
5.4 Swot Analysis; By Factor (Political & Legal, Economic And Technological)
5.5 Porter’s Five Forces Analysis
5.6 Regulatory Framework
CHAPTER 6 THE U.S. RADIATION ONCOLOGY MARKET - SEGMENT ANALYSIS, BY TYPE, 2016 - 2027 (USD MILLION)(VOLUME, NUMBER OF UNITS)
6.1 The U.S. Radiation Oncology Market: Type Movement Analysis
6.2 External Beam Radiation Therapy
6.2.1 External Beam Radiation Therapy Market, 2016 - 2027 (USD Million)
6.2.2 external Beam Radiation Therapy Market, 2016 - 2027 (Volume, Number Of Units)
6.2.3 Electron-Emitting High Energy Linear Accelerators
6.2.3.1 Electron-Emitting High Energy Linear Accelerators Market, 2016 - 2027 (USD Million)
6.2.3.2 Electron-Emitting High Energy Linear Accelerators Market, 2016 - 2027 (Volume, Number Of Units)
6.2.4 Compact Advanced Radiotherapy Systems
6.2.4.1 Compact Advanced Radiotherapy Systems Market, 2016 - 2027 (USD Million)
6.2.4.2 compact Advanced Radiotherapy Systems Market, 2016 - 2027 (Volume, Number Of Units)
6.2.4.3 Cyberknife
6.2.4.3.1 Cyberknife Market, 2016 - 2027 (USD Million)
6.2.4.4 Gamma Knife
6.2.4.4.1 Gamma Knife Market, 2016 - 2027 (USD Million)
6.2.4.5 Tomotherapy
6.2.4.5.1 Tomotherapy Compact Market, 2016 - 2027 (USD Million)
6.2.5 Proton Therapy
6.2.5.1 Proton Therapy Market, 2016 - 2027 (USD Million)
6.2.5.2 Proton Therapy Market, 2016 - 2027 (Volume, Number Of Units)
6.2.5.3 Cyclotron
6.2.5.3.1 Cyclotron Market, 2016 - 2027 (USD Million)
6.2.5.4 Synchrotron
6.2.5.4.1 Synchrotron Market, 2016 - 2027 (USD Million)
6.3 Internal Beam Radiation Therapy
6.3.1 Internal Beam Radiation Therapy Market, 2016 - 2027 (USD Million)
6.3.2 Internal Beam Radiation Therapy Market, 2016 - 2027 (Volume, Number Of Units)
6.3.3 Brachytherapy
6.3.3.1 Brachytherapy Market, 2016 - 2027 (USD Million)
6.3.3.2 Brachytherapy Market, 2016 - 2027 (Volume, Number Of Units)
6.3.3.3 Seeds
6.3.3.3.1 Seeds Market, 2016 - 2027 (USD Million)
6.3.3.4 Applicators And After-Loaders
6.3.3.4.1 Applicators And After-Loaders Market, 2016 - 2027 (USD Million)
6.3.3.4 Electronic Brachytherapy
6.3.3.4.1 Electronic Brachytherapy Market, 2016 - 2027 (USD Million)
6.3.4 Systemic Beam Radiation Therapy
6.3.4.1 Systemic Beam Radiation Therapy Market, 2016 - 2027 (USD Million)
6.3.3.2 Brachytherapy Market, 2016 - 2027 (Volume, Number Of Units)
6.3.5 Others
6.3.5.1 Others Market, 2016 - 2027 (USD Million)
CHAPTER 7 THE U.S. RADIATION ONCOLOGY MARKET - SEGMENT ANALYSIS, BY TECHNOLOGY, 2016 - 2027 (USD MILLION)(VOLUME, NUMBER OF UNITS)
7.1 The U.S. Radiation Oncology Market: Technology Movement Analysis
7.2 External Beam Radiation Therapy (Ebrt)
7.2.1 Ebrt Market, 2016 - 2027 (USD Million)
7.2.2 Ebrt Market, 2016 - 2027 (Volume, Number Of Procedures)
7.2.3 Image-Guided Radiation Therapy (Igrt)
7.2.3.1 Igrt Market, 2016 - 2027 (USD Million)
7.2.3.2 Igrt Market, 2016 - 2027 (Volume, Number Of Procedures)
7.2.4 Intensity Modulated Radiotherapy (Imrt)
7.2.4.1 Imrt Market, 2016 - 2027 (USD Million)
7.2.4.2imrt Market, 2016 - 2027 (Volume, Number Of Procedures)
7.2.5 Stereotactic Radiotherapy
7.2.5.1 Stereotactic Radiotherapy Market, 2016 - 2027 (Volume, Number Of Procedures)
7.2.5.2stereotactic Radiotherapy Market, 2016 - 2027 (USD Million)
7.2.6 Proton Beam Therapy
7.2.6.1 Proton Beam Therapy Market, 2016 - 2027 (USD Million)
7.2.6.2proton Beam Therapy Market, 2016 - 2027 (Volume, Number Of Procedures)
7.2.7 3d Conformal Radiotherapy (3d-Crt)
7.2.7.1 3d-Crt Market, 2016 - 2027 (USD Million)
7.2.7.2 3d-Crt Market, 2016 - 2027 (Volume, Number Of Procedures)
7.2.8 Volumetric Modulated Arc Therapy (Vmat)
7.2.8.1 Vmat Market, 2016 - 2027 (USD Million)
7.2.8.2vmat Market, 2016 - 2027 (Volume, Number Of Procedures)
7.3 Brachytherapy
7.3.1 Brachytherapy Market, 2016 - 2027 (USD Million)
7.3.2 Brachytherapy Market, 2016 - 2027 (Volume, Number Of Units)
7.3.3 Low Dose Rate (Ldr) Brachytherapy
7.3.3.1 Ldr Brachytherapy Market, 2016 - 2027 (USD Million)
7.3.3.2ldr Brachytherapy Market, 2016 - 2027 (Volume, Number Of Units)
7.3.4 High Dose Rate (Hdr) Brachytherapy
7.3.4.1 Hdr Brachytherapy Market, 2016 - 2027 (USD Million)
7.3.4.2 hdr Brachytherapmarket, 2016 - 2027 (Volume, Number Of Units)
CHAPTER 8 THE U.S. RADIATION ONCOLOGY MARKET - SEGMENT ANALYSIS, BY APPLICATION, 2016 - 2027 (USD MILLION)(VOLUME, NUMBER OF PROCEDURES)
8.1 The U.S. Radiation Oncology Market: Application Movement Analysis
8.2 External Beam Radiation Therapy (Ebrt)
8.2.1 Prostate Cancer
8.2.1.1 Prostate Cancer Market, 2016 - 2027 (USD Million)
8.2.1.2 Prostate Cancer Market, 2016 - 2027 (Volume, Number Of Procedures)
8.2.2 Breast Cancer
8.2.2.1 Breast Cancer Market, 2016 - 2027 (USD Million)
8.2.2.2 Breast Cancer Market, 2016 - 2027 (Volume, Number Of Procedures)
8.2.3 Lung Cancer
8.2.3.1 Lung Cancer Market, 2016 - 2027 (USD Million)
8.2.3.2 Lung Cancer Market, 2016 - 2027 (Volume, Number Of Procedures)
8.2.4 Head And Neck Cancer
8.2.4.1 Head And Neck Cancer Market, 2016 - 2027 (USD Million)
8.2.4.2 Head And Neck Cancer Market, 2016 - 2027 (Volume, Number Of Procedures)
8.2.5 Colorectal cancer
8.2.5.1 Colorectal Cancer Market, 2016 - 2027 (USD Million)
8.2.5.2 Colorectal Cancer Market, 2016 - 2027 (Volume, Number Of Procedures)
8.2.6 Others
8.2.6.1 Others Market, 2016 - 2027 (USD Million)
8.3 Internal Beam Radiation Therapy
8.3.1 Prostate Cancer
8.3.1.1 Prostate Cancer Market, 2016 - 2027 (USD Million)
8.3.1.2 Prostate Cancer Market, 2016 - 2027 (Volume, Number Of Procedures)
8.3.2 Gynecologic Cancer
8.3.2.1 Gynecologic Cancer Market, 2016 - 2027 (USD Million)
8.3.2.2 Gynecologic Cancer Market, 2016 - 2027 (Volume, Number Of Procedures)
8.3.3 Breast Cancer
8.3.3.1 Breast Cancer Market, 2016 - 2027 (USD Million)
8.3.3.2 Breast Cancer Market, 2016 - 2027 (Volume, Number Of Procedures N)
8.3.4 Cervical Cancer
8.3.4.1 Cervical Cancer Market, 2016 - 2027 (USD Million)
8.3.4.2 Cervical Cancer Market, 2016 - 2027 (Volume, Number Of Procedures)
8.3.5 Penile Cancer
8.3.5.1 Penile Cancer Market, 2016 - 2027 (USD Million)
8.3.5.2 Penile Cancer Market, 2016 - 2027 (Volume, Number Of Procedures)
8.3.6 Others
8.3.6.1 Others Market, 2016 - 2027 (USD Million)
CHAPTER 9 COMPETITIVE LANDSCAPE
9.1 Strategic Framework
9.2 Company Profiles
9.2.1 Varian Medical Systems, Inc.
9.2.1.1 Company Overview
9.2.1.2 Financial Performance
9.2.1.3 Product Benchmarking
9.2.1.4 Strategic Initiatives
9.2.2 Elekta Ab
9.2.2.1 Company Overview
9.2.2.2 Financial Performance
9.2.2.3 Product Benchmarking
9.2.2.4 Strategic Initiatives
9.2.3 Accuray Inc.
9.2.3.1 Company Overview
9.2.3.2 Financial Performance
9.2.3.3 Product Benchmarking
9.2.3.4 Strategic Initiatives
9.2.4 C.R. Bard, Inc.
9.2.4.1 Company Overview
9.2.4.2 Financial Performance
9.2.4.3 Product Benchmarking
9.2.4.4 Strategic Initiatives
9.2.5 Mevion Medical Systems
9.2.5.1 Company Overview
9.2.5.2 Product Benchmarking
9.2.5.3 Strategic Initiatives
9.2.6 Ion Beam Applications (Iba).
9.2.6.1 Company Overview
9.2.6.2 Financial Performance
9.2.6.3 Product Benchmarking
9.2.6.4 Strategic Initiatives
9.2.7 Curium
9.2.7.1 Company Overview
9.2.7.2 Product Benchmarking
9.2.8 Nordion Inc.
9.2.8.1 Company Overview
9.2.8.2 Product Benchmarking
9.2.8.3 Strategic Initiatives
9.3 Vendor Landscape
9.3.1 List Of Key Distributors And Channel Partners
9.3.2 Key Company Market Share Analysis, 2019
9.4 Public Companies
9.4.1 Company Market Position Analysis
9.4.2 Competitive Dashboard Analysis
9.5 Private Companies
9.5.1 List Of Key Emerging Companies /Technology Disruptors/Innovators
9.5.2 Geographical Network Map
LIST OF TABLES
Table 1 List of secondary sources
Table 2 List of reimbursement for radiation therapy
Table 3 Reimbursement for IMRT services
Table 4 Reimbursement for IGRT services
Table 5 List of key distributors
Table 6 List of key emerging companies /technology disruptors/innovators
Table 7 The U.S. Radiation Oncology Market, By Type, 2016 - 2027 (USD Million)
Table 8 The U.S. Radiation Oncology Market, By Type, 2016 - 2027 (Volume in units)
Table 9 The U.S. Internal Beam Radiation Therapy Market, By Type,2016 - 2027 (USD Million)
Table 10 The U.S. Internal Beam Radiation Therapy Market, By Type,2016 - 2027 (Volume in units)
Table 11 The U.S. External Beam Radiation Therapy Market, By Type, 2016 - 2027 (USD Million)
Table 12 The U.S. External Beam Radiation Therapy Market, By Type, 2016 - 2027 (Volume in units)
Table 13 The U.S. Compact Advanced Radiotherapy Systems Market, by Product Type, 2016 - 2027 (USD Million)
Table 14 The U.S. Proton Therapy Market, by Product Type, 2016 - 2027 (USD Million)
Table 15 The U.S. Brachytherapy Market, by Product Type, 2016 - 2027 (USD Million)
Table 16 The U.S. External Beam Radiation Therapy Market, By Technology, 2016 - 2027 (USD Million)
Table 17 The U.S. External Beam Radiation Therapy Market, By Technology, 2016 - 2027 (Volume (number of procedures))
Table 18 The U.S. Brachytherapy Market, By Technology, 2016 - 2027 (USD Million)
Table 19 The U.S. Brachytherapy Market, By Technology, 2016 - 2027 (Volume in units)
Table 20 The U.S. External Beam Radiation Therapy Market, By Application, 2016 - 2027 (USD Million)
Table 21 The U.S. External Beam Radiation Therapy Market, By Application, 2016 - 2027 (Volume (number of procedures))
Table 22 The U.S. Internal Beam Radiation Therapy Market, By Application, 2016 - 2027 (USD Million)
Table 23 The U.S. Internal Beam Radiation Therapy Market, By Application, 2016 - 2027 (Volume (number of procedures))
Table 24 The U.S. Brachytherapy Market, By Application, 2016 - 2027 (Volume (number of procedures))
Table 1 List of secondary sources
Table 2 List of reimbursement for radiation therapy
Table 3 Reimbursement for IMRT services
Table 4 Reimbursement for IGRT services
Table 5 List of key distributors
Table 6 List of key emerging companies /technology disruptors/innovators
Table 7 The U.S. Radiation Oncology Market, By Type, 2016 - 2027 (USD Million)
Table 8 The U.S. Radiation Oncology Market, By Type, 2016 - 2027 (Volume in units)
Table 9 The U.S. Internal Beam Radiation Therapy Market, By Type,2016 - 2027 (USD Million)
Table 10 The U.S. Internal Beam Radiation Therapy Market, By Type,2016 - 2027 (Volume in units)
Table 11 The U.S. External Beam Radiation Therapy Market, By Type, 2016 - 2027 (USD Million)
Table 12 The U.S. External Beam Radiation Therapy Market, By Type, 2016 - 2027 (Volume in units)
Table 13 The U.S. Compact Advanced Radiotherapy Systems Market, by Product Type, 2016 - 2027 (USD Million)
Table 14 The U.S. Proton Therapy Market, by Product Type, 2016 - 2027 (USD Million)
Table 15 The U.S. Brachytherapy Market, by Product Type, 2016 - 2027 (USD Million)
Table 16 The U.S. External Beam Radiation Therapy Market, By Technology, 2016 - 2027 (USD Million)
Table 17 The U.S. External Beam Radiation Therapy Market, By Technology, 2016 - 2027 (Volume (number of procedures))
Table 18 The U.S. Brachytherapy Market, By Technology, 2016 - 2027 (USD Million)
Table 19 The U.S. Brachytherapy Market, By Technology, 2016 - 2027 (Volume in units)
Table 20 The U.S. External Beam Radiation Therapy Market, By Application, 2016 - 2027 (USD Million)
Table 21 The U.S. External Beam Radiation Therapy Market, By Application, 2016 - 2027 (Volume (number of procedures))
Table 22 The U.S. Internal Beam Radiation Therapy Market, By Application, 2016 - 2027 (USD Million)
Table 23 The U.S. Internal Beam Radiation Therapy Market, By Application, 2016 - 2027 (Volume (number of procedures))
Table 24 The U.S. Brachytherapy Market, By Application, 2016 - 2027 (Volume (number of procedures))
LIST OF FIGURES
Fig. 1 The U.S. radiation oncology market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 The U.S. radiation oncology market snapshot
Fig. 10 The U.S. radiation oncology market segmentation
Fig. 11 Key market opportunities
Fig. 12 The U.S. radiation oncology market driver impact
Fig. 13 New cancer cases in 2020
Fig. 14 Cancer deaths in 2020
Fig. 15 The U.S. radiation oncology market restraint impact
Fig. 16 SWOT analysis, by factor (political & legal economic and technological)
Fig. 17 Porter’s five forces analysis
Fig. 18 The U.S. radiation oncology market: Type outlook and key takeaways
Fig. 19 The U.S. radiation oncology market: Type movement analysis
Fig. 20 External beam radiation therapy market, 2016 - 2027 (USD Million)
Fig. 21 External beam radiation therapy market, 2016 - 2027 (Volume, number of units)
Fig. 22 Electron-emitting high energy linear accelerators market, 2016 - 2027 (USD Million)
Fig. 23 Electron-emitting high energy linear accelerators market, 2016 - 2027 (Volume, number of units)
Fig. 24 Compact advanced radiotherapy systems market, 2016 - 2027 (USD Million)
Fig. 25 Compact advanced radiotherapy systems market, 2016 - 2027 (Volume, number of units)
Fig. 26 CyberKnife market, 2016 - 2027 (USD Million)
Fig. 27 Gamma Knife market, 2016 - 2027 (USD Million)
Fig. 28 Tomotherapy market, 2016 - 2027 (USD Million)
Fig. 29 Proton therapy market, 2016 - 2027 (USD Million)
Fig. 30 Proton therapy market, 2016 - 2027 (Volume, number of units)
Fig. 31 Cyclotron market, 2016 - 2027 (USD Million)
Fig. 32 Synchrotron market, 2016 - 2027 (USD Million)
Fig. 33 Internal beam radiation therapy market, 2016 - 2027 (USD Million)
Fig. 34 Internal beam radiation therapy market, 2016 - 2027 (Volume, number of units)
Fig. 35 Brachytherapy market, 2016 - 2027 (USD Million)
Fig. 36 Brachytherapy market, 2016 - 2027 (Volume, number of units)
Fig. 37 Seeds market, 2016 - 2027 (USD Million)
Fig. 38 Applicators and after-loaders market, 2016 - 2027 (USD Million)
Fig. 39 Electronic brachytherapy market, 2016 - 2027 (USD Million)
Fig. 40 Systemic beam radiation therapy market, 2016 - 2027 (USD Million)
Fig. 41Systemic beam radiation therapy market, 2016 - 2027 (Volume, number of units)
Fig. 42 Others market, 2016 - 2027 (USD Million)
Fig. 43 The U.S. radiation oncology market: Technology outlook and key takeaways
Fig. 44 The U.S. radiation oncology market: Technology movement analysis
Fig. 45 EBRT market, 2016 - 2027 (USD Million)
Fig. 46 EBRT market, 2016 - 2027 (Volume, number of procedures)
Fig. 47 IGRT market, 2016 - 2027 (USD Million)
Fig. 48 IGRT market, 2016 - 2027 (Volume, number of procedures)
Fig. 49 IMRT market, 2016 - 2027 (USD Million)
Fig. 50 IMRT market, 2016 - 2027 (Volume, number of procedures)
Fig. 51 Stereotactic radiotherapy market, 2016 - 2027 (USD Million)
Fig. 52 Stereotactic radiotherapy market, 2016 - 2027 (Volume, number of procedures)
Fig. 52 Proton beam therapy market, 2016 - 2027 (USD Million)
Fig. 53 Proton beam therapy market, 2016 - 2027 (Volume, number of procedures)
Fig. 54 3D-CRT market, 2016 - 2027 (USD Million)
Fig. 55 3D-CRT market, 2016 - 2027 (Volume, number of procedures)
Fig. 56 VMAT market, 2016 - 2027 (USD Million)
Fig. 57 VMAT market, 2016 - 2027 (Volume, number of procedures)
Fig. 58 Brachytherapy market, 2016 - 2027 (USD Million)
Fig. 59 Brachytherapy market, 2016 - 2027 (Volume, number of units)
Fig. 60 LDR brachytherapy market, 2016 - 2027 (USD Million)
Fig. 61 LDR Brachytherapy market, 2016 - 2027 (Volume, number of units)
Fig. 62 HDR brachytherapy market, 2016 - 2027 (USD Million)
Fig. 63 HDR Brachytherapy market, 2016 - 2027 (Volume, number of units)
Fig. 64 The U.S. radiation oncology market: Application outlook and key takeaways
Fig. 65 The U.S. radiation oncology market: Application movement analysis
Fig. 66 Prostate cancer market, 2016 - 2027 (USD Million)
Fig. 67 Prostate cancer market, 2016 - 2027 (Volume, number of procedures)
Fig. 68 Breast cancer market, 2016 - 2027 (USD Million)
Fig. 69 Breast cancer market, 2016 - 2027 (Volume, number of procedures)
Fig. 70 Lung cancer market, 2016 - 2027 (USD Million)
Fig. 71 Lung cancer market, 2016 - 2027 (Volume, number of procedures)
Fig. 72 Head and neck cancer market, 2016 - 2027 (USD Million)
Fig. 73 Head and neck cancer market, 2016 - 2027 (Volume, number of procedures)
Fig. 74 Colorectal cancer market, 2016 - 2027 (USD Million)
Fig. 75 Colorectal cancer market, 2016 - 2027 (Volume, number of procedures)
Fig. 76 Others market, 2016 - 2027 (USD Million)
Fig. 77 Prostate cancer market, 2016 - 2027 (USD Million)
Fig. 78 Prostate cancer market, 2016 - 2027 (Volume, number of procedures)
Fig. 79 Gynecological cancer market, 2016 - 2027 (USD Million)
Fig. 80 Gynecological cancer market, 2016 - 2027 (Volume, number of procedures)
Fig. 81 Breast cancer market, 2016 - 2027 (USD Million)
Fig. 82 Breast cancer market, 2016 - 2027 (Volume, number of procedures)
Fig. 83 Cervical cancer market, 2016 - 2027 (USD Million)
Fig. 84 Cervical cancer market, 2016 - 2027 (Volume, number of procedures)
Fig. 85 Penile cancer market, 2016 - 2027 (USD Million)
Fig. 86 Penile cancer market, 2016 - 2027 (Volume, number of procedures)
Fig. 87 Others market, 2016 - 2027 (USD Million)
Fig. 88 Strategic Framework
Fig. 89 Company market share analysis, 2019
Fig. 90 Company market position analysis (Total revenue & operating profit)
Fig. 91 Company market position analysis (Profit margin)
Fig. 92 Competitive dashboard analysis
Fig. 93 Geographical network map
Fig. 1 The U.S. radiation oncology market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 The U.S. radiation oncology market snapshot
Fig. 10 The U.S. radiation oncology market segmentation
Fig. 11 Key market opportunities
Fig. 12 The U.S. radiation oncology market driver impact
Fig. 13 New cancer cases in 2020
Fig. 14 Cancer deaths in 2020
Fig. 15 The U.S. radiation oncology market restraint impact
Fig. 16 SWOT analysis, by factor (political & legal economic and technological)
Fig. 17 Porter’s five forces analysis
Fig. 18 The U.S. radiation oncology market: Type outlook and key takeaways
Fig. 19 The U.S. radiation oncology market: Type movement analysis
Fig. 20 External beam radiation therapy market, 2016 - 2027 (USD Million)
Fig. 21 External beam radiation therapy market, 2016 - 2027 (Volume, number of units)
Fig. 22 Electron-emitting high energy linear accelerators market, 2016 - 2027 (USD Million)
Fig. 23 Electron-emitting high energy linear accelerators market, 2016 - 2027 (Volume, number of units)
Fig. 24 Compact advanced radiotherapy systems market, 2016 - 2027 (USD Million)
Fig. 25 Compact advanced radiotherapy systems market, 2016 - 2027 (Volume, number of units)
Fig. 26 CyberKnife market, 2016 - 2027 (USD Million)
Fig. 27 Gamma Knife market, 2016 - 2027 (USD Million)
Fig. 28 Tomotherapy market, 2016 - 2027 (USD Million)
Fig. 29 Proton therapy market, 2016 - 2027 (USD Million)
Fig. 30 Proton therapy market, 2016 - 2027 (Volume, number of units)
Fig. 31 Cyclotron market, 2016 - 2027 (USD Million)
Fig. 32 Synchrotron market, 2016 - 2027 (USD Million)
Fig. 33 Internal beam radiation therapy market, 2016 - 2027 (USD Million)
Fig. 34 Internal beam radiation therapy market, 2016 - 2027 (Volume, number of units)
Fig. 35 Brachytherapy market, 2016 - 2027 (USD Million)
Fig. 36 Brachytherapy market, 2016 - 2027 (Volume, number of units)
Fig. 37 Seeds market, 2016 - 2027 (USD Million)
Fig. 38 Applicators and after-loaders market, 2016 - 2027 (USD Million)
Fig. 39 Electronic brachytherapy market, 2016 - 2027 (USD Million)
Fig. 40 Systemic beam radiation therapy market, 2016 - 2027 (USD Million)
Fig. 41Systemic beam radiation therapy market, 2016 - 2027 (Volume, number of units)
Fig. 42 Others market, 2016 - 2027 (USD Million)
Fig. 43 The U.S. radiation oncology market: Technology outlook and key takeaways
Fig. 44 The U.S. radiation oncology market: Technology movement analysis
Fig. 45 EBRT market, 2016 - 2027 (USD Million)
Fig. 46 EBRT market, 2016 - 2027 (Volume, number of procedures)
Fig. 47 IGRT market, 2016 - 2027 (USD Million)
Fig. 48 IGRT market, 2016 - 2027 (Volume, number of procedures)
Fig. 49 IMRT market, 2016 - 2027 (USD Million)
Fig. 50 IMRT market, 2016 - 2027 (Volume, number of procedures)
Fig. 51 Stereotactic radiotherapy market, 2016 - 2027 (USD Million)
Fig. 52 Stereotactic radiotherapy market, 2016 - 2027 (Volume, number of procedures)
Fig. 52 Proton beam therapy market, 2016 - 2027 (USD Million)
Fig. 53 Proton beam therapy market, 2016 - 2027 (Volume, number of procedures)
Fig. 54 3D-CRT market, 2016 - 2027 (USD Million)
Fig. 55 3D-CRT market, 2016 - 2027 (Volume, number of procedures)
Fig. 56 VMAT market, 2016 - 2027 (USD Million)
Fig. 57 VMAT market, 2016 - 2027 (Volume, number of procedures)
Fig. 58 Brachytherapy market, 2016 - 2027 (USD Million)
Fig. 59 Brachytherapy market, 2016 - 2027 (Volume, number of units)
Fig. 60 LDR brachytherapy market, 2016 - 2027 (USD Million)
Fig. 61 LDR Brachytherapy market, 2016 - 2027 (Volume, number of units)
Fig. 62 HDR brachytherapy market, 2016 - 2027 (USD Million)
Fig. 63 HDR Brachytherapy market, 2016 - 2027 (Volume, number of units)
Fig. 64 The U.S. radiation oncology market: Application outlook and key takeaways
Fig. 65 The U.S. radiation oncology market: Application movement analysis
Fig. 66 Prostate cancer market, 2016 - 2027 (USD Million)
Fig. 67 Prostate cancer market, 2016 - 2027 (Volume, number of procedures)
Fig. 68 Breast cancer market, 2016 - 2027 (USD Million)
Fig. 69 Breast cancer market, 2016 - 2027 (Volume, number of procedures)
Fig. 70 Lung cancer market, 2016 - 2027 (USD Million)
Fig. 71 Lung cancer market, 2016 - 2027 (Volume, number of procedures)
Fig. 72 Head and neck cancer market, 2016 - 2027 (USD Million)
Fig. 73 Head and neck cancer market, 2016 - 2027 (Volume, number of procedures)
Fig. 74 Colorectal cancer market, 2016 - 2027 (USD Million)
Fig. 75 Colorectal cancer market, 2016 - 2027 (Volume, number of procedures)
Fig. 76 Others market, 2016 - 2027 (USD Million)
Fig. 77 Prostate cancer market, 2016 - 2027 (USD Million)
Fig. 78 Prostate cancer market, 2016 - 2027 (Volume, number of procedures)
Fig. 79 Gynecological cancer market, 2016 - 2027 (USD Million)
Fig. 80 Gynecological cancer market, 2016 - 2027 (Volume, number of procedures)
Fig. 81 Breast cancer market, 2016 - 2027 (USD Million)
Fig. 82 Breast cancer market, 2016 - 2027 (Volume, number of procedures)
Fig. 83 Cervical cancer market, 2016 - 2027 (USD Million)
Fig. 84 Cervical cancer market, 2016 - 2027 (Volume, number of procedures)
Fig. 85 Penile cancer market, 2016 - 2027 (USD Million)
Fig. 86 Penile cancer market, 2016 - 2027 (Volume, number of procedures)
Fig. 87 Others market, 2016 - 2027 (USD Million)
Fig. 88 Strategic Framework
Fig. 89 Company market share analysis, 2019
Fig. 90 Company market position analysis (Total revenue & operating profit)
Fig. 91 Company market position analysis (Profit margin)
Fig. 92 Competitive dashboard analysis
Fig. 93 Geographical network map
